<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04558775</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00176334</org_study_id>
    <secondary_id>1U24DK122927-01</secondary_id>
    <nct_id>NCT04558775</nct_id>
  </id_info>
  <brief_title>TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence</brief_title>
  <acronym>TEWL</acronym>
  <official_title>Tran-epidermal Water Loss (TEWL) as a Predictive Marker for Diabetic Foot Ulcer (DFU) Recurrence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter study of patients with diabetic foot ulcers (DFU) to develop and&#xD;
      validate potential tissue-based biomarkers that predict DFU wound recurrence. Trans-epidermal&#xD;
      water loss (TEWL) will be measured on the closed wound site and a location similar to the&#xD;
      wound site (reference site). Participants will be enrolled within two weeks after closure of&#xD;
      their DFU. Complete wound healing will be verified at a second visit two weeks later and this&#xD;
      visit will start the 16 week timeline where participants will be followed weekly by phone&#xD;
      until the earliest of DFU wound recurrence or 16 weeks. Participants who experience a DFU&#xD;
      wound recurrence and a subset of participants who do not experience a DFU wound recurrence by&#xD;
      week 16 will be asked to attend one final visit.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 17, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants who have DFU wound recurrence by 16 weeks after complete wound healing</measure>
    <time_frame>1 up to 16 weeks after wound closure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to DFU wound recurrence after complete wound healing</measure>
    <time_frame>Up to 16 weeks after wound closure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant self-report of DFU wound recurrence</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinician assessment of DFU wound recurrence</measure>
    <time_frame>16 weeks</time_frame>
    <description>Concordance between participant self-report and clinician assessment of DFU wound recurrence is important to provide confidence in the use of patient-reports for the primary endpoint.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">402</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetic Foot</condition>
  <condition>Diabetic Foot Ulcer</condition>
  <condition>Diabetic Wound</condition>
  <condition>Diabetic</condition>
  <arm_group>
    <arm_group_label>Observational Cohort</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>no intervention</description>
    <arm_group_label>Observational Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult diabetic patients with diabetic foot ulcer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        In order to be eligible to participate in this study, an individual must meet all of the&#xD;
        following criteria at Visit 1:&#xD;
&#xD;
          1. Age &gt; 18 years.&#xD;
&#xD;
          2. Willing and able to comply with protocol instructions.&#xD;
&#xD;
          3. Clinically diagnosed DFU is closed.&#xD;
&#xD;
          4. Clinically diagnosed with diabetes or meeting the American Diabetes Association (ADA)&#xD;
             criteria.&#xD;
&#xD;
          5. Provides written informed consent.&#xD;
&#xD;
             At Visit 2, confirmation of complete wound healing, the following additional inclusion&#xD;
             criterion must be met:&#xD;
&#xD;
          6. Confirmation that the target DFU that was assessed as healed at Visit 1 remains healed&#xD;
             two weeks later (at Visit 2).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        An individual who meets any of the following criteria will be excluded from participation&#xD;
        in this study:&#xD;
&#xD;
          1. DFU wounds closed more than 2 weeks before Visit 1, or to be closed by flap or graft&#xD;
             coverage&#xD;
&#xD;
          2. Closed DFU site whose size or location would not allow five separate TEWL measurements&#xD;
&#xD;
          3. Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chandan K Sen, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brandi K Gizinski</last_name>
    <phone>7347633632</phone>
    <email>DFC-DCC-PM@umich.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katy Clark</last_name>
    <email>DFC-DCC-PM@umich.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California - San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Onorio Antonucci</last_name>
      <phone>415-353-4379</phone>
      <email>onorio.antonucci@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Conte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Meyer</last_name>
      <email>smeyer72@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Geoffrey Gurtner, MD, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33126</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aliette Espinosa</last_name>
      <phone>305-689-3376</phone>
      <email>a.espinosa2@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Robert S Kirsner, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryce Hockman</last_name>
      <phone>317-278-2715</phone>
      <email>bbhockma@iu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Henry Ludwig</last_name>
      <phone>317-278-2715</phone>
      <email>hbludwig@iu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Chandan K Sen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Burant</last_name>
      <phone>734-615-0552</phone>
      <email>aburant@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Rodica Pop-Busui, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>25261</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>September 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Cathie Spino, ScD</investigator_full_name>
    <investigator_title>Research Professor of Biostatistics, SABER Director</investigator_title>
  </responsible_party>
  <keyword>biomarker</keyword>
  <keyword>TEWL</keyword>
  <keyword>trans epidermal water loss</keyword>
  <keyword>DFC</keyword>
  <keyword>Diabetic Foot Consortium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

